Moleculin Biotech Inc (MBRX): Proceed With Caution
Moleculin Biotech Inc (NASDAQ:MBRX), an oncology-focused pharmaceutical firm that just joined public markets in June, is making some waves in the biotech world.
Metabasis Therapeutics Inc (MBRX)
Market is closed
Billionaire Hedge Funds
